Budapest, Hungary

Gyula Balogh, Deceased

This inventor holds 1 USPTO granted patent. Top assignee: Egis Gyogyszergyar Rt.. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gyula Balogh, Deceased. Retrieved from https://idiyas.com/inventor/gyula-balogh-deceased

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gyula Balogh: A Legacy in Pharmaceutical Innovation

Introduction

Gyula Balogh was a notable inventor in the field of pharmaceuticals, recognized for his contributions to the development of anxiolytic compositions. His work has had a lasting impact on the industry, particularly in the area of heterocyclic compounds.

Latest Patents

Balogh held a patent for "Heterocyclic compounds, pharmaceutical compositions comprising them." This invention specifically relates to anxiolytic pharmaceutical compositions that utilize 1-sytrylisoquinoline derivatives of a general formula. His innovative approach has paved the way for advancements in anxiety treatment.

Career Highlights

Throughout his career, Balogh was associated with Egis Gyógyszergyár Rt., a prominent pharmaceutical company in Hungary. His dedication to research and development has contributed significantly to the field, showcasing his expertise and commitment to improving healthcare solutions.

Collaborations

Balogh collaborated with several talented individuals, including Imre Doman and Gabor Blasko. These partnerships were instrumental in advancing his research and enhancing the quality of his inventions.

Conclusion

Gyula Balogh's contributions to pharmaceutical innovation, particularly in the development of anxiolytic compositions, have left a significant mark on the industry. His legacy continues to inspire future generations of inventors and researchers.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…